Marlboro Maker's Radical Health Foray Upends Role of Big Tobacco.

CIGARETTES; ELECTRONIC cigarettes; TOBACCO; NICOTINE replacement therapy; PRIVATE equity funds; TOBACCO products

In one of its boldest and most controversial moves yet, the company said this month that it would buy U.K. asthma drug maker Vectura Group Plc, a deal that would add fresh expertise in devices, inhalation, regulation and clinical manufacturing. Keywords: 3400398Z; 6949817ZLN; BATS@LN; CG; IMB@LN; PM; VEC@LN; ALLTOP; BUSINESS; CONS; CONSD; CONSS; COS; DRG; EUROPE; GEN; GOV; HEA; INDUSTRIAL; INDUSTRIES; LEI; MAC; NORTHAM; POL; RET; TOP; UK; US; WORLD; WWTOP; WWTOPAM EN 3400398Z 6949817ZLN BATS@LN CG IMB@LN PM VEC@LN ALLTOP BUSINESS CONS CONSD CONSS COS DRG EUROPE GEN GOV HEA INDUSTRIAL INDUSTRIES LEI MAC NORTHAM POL RET TOP UK US WORLD WWTOP WWTOPAM Philip Morris's purchase of an inhaler maker has proven controversial QWL92JDWX2QB (Bloomberg) -- When Moira Gilchrist was first approached by Philip Morris International Inc., she wondered what a tobacco company wanted from a scientist who had previously worked on clinical trials for anti-cancer drugs. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)